<DOC>
	<DOCNO>NCT01631656</DOCNO>
	<brief_summary>The purpose study compare efficacy outcome treatment azelaic acid ( Finacea Gel ) Vascular ND : Yag laser therapy versus Vascular ND : Yag laser therapy alone via split face study design approximately ten fifteen subject mild moderate rosacea . We hypothesize treatment rosacea combination azelaic acid ( Finacea Gel ) Vascular ND : Yag laser therapy lead great improvement lesion count , redness telangiectasias compare treatment Vascular ND : Yag laser therapy alone .</brief_summary>
	<brief_title>Combination Gel Vascular ND Mild Moderate Rosacea</brief_title>
	<detailed_description>This single center , open-label , split-face , prospective study ten fifteen subject seek vascular laser therapy treatment mild moderate rosacea . Subjects screen eligibility vascular laser therapy outside confines protocol . Once approve laser , subject screen study enrollment topical treatment rosacea Screening/Baseline visit . All subject receive Finacea 15 % gel instruct apply study drug one half face , twice daily . Drug application modify prior subject ' laser treatment reduce irritation . Subjects undergo Vascular Nd : Yag laser therapy involve area whole face two week initiate Finacea treatment . Subjects continue use Finacea gel one half face duration study . Assessment acneiform lesion , redness , telangiectasias perform Screening/Baseline , Week 2 ( prior laser treatment ) , week 6/End Study . Photography perform Screening/Baseline End Study visit . Adverse event assess visit , patient survey complete Baseline Week 6/End Study visit .</detailed_description>
	<mesh_term>Rosacea</mesh_term>
	<mesh_term>Azelaic acid</mesh_term>
	<criteria>Male female subject mild moderate rosacea , age 18 , agree participate provide write consent . Have Investigator Global Assessment mild moderate rosacea ( IGA rating 2 5 Investigator Global Assessment ( Appendix B ) least `` Mild '' rating Telangiectasia Rating Scale Subjects must eligible undergo vascular laser therapy previously approve therapy . Initiation change dose within 4 week baseline systemic anti‐inflammatory medication may influence study outcome . Use topical therapy rosacea within 2 week baseline . Use systemic corticosteroid within 4 week baseline . Use systemic retinoids within 6 month baseline Presence concurrent medical condition skin condition , determine investigator potentially interfere study outcome patient assessment . Amount disease involvement would require &gt; 60 gm cream 6 week period . Subjects know allergy sensitivity azelaic acid ( Finacea® ) gel component therein , propylene glycol . Contraindication vascular laser therapy , infection . Female subject postmenopausal least 1 year , surgically sterile , willing practice effective contraception study . Reliable method birth control : abstinence ( sex ) , oral contraceptive , intrauterine device ( IUD ) , DepoProvera , tubal ligation , vasectomy partner ( confirm negative sperm count ) monogamous relationship ( partner ) . An acceptable , although less reliable , method involves careful use condom spermicidal foam gel and/or cervical cap sponge . Nursing mother , pregnant woman woman plan become pregnant study exclude .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2016</verification_date>
	<keyword>Rosacea , Mild , Moderate , Combination Therapy , Laser , Finacea Gel , Azelaic Acid ,</keyword>
</DOC>